Related references
Note: Only part of the references are listed.Therapeutic Outcomes and Prognostic Impact of Gene Mutations Including TP53 and SF3B1 in Patients with Del(5q) Myelodysplastic Syndromes (MDS)
Onyee Chan et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2022)
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
Daniel A. Arber et al.
BLOOD (2022)
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms
Joseph D. Khoury et al.
LEUKEMIA (2022)
Pathologic Spectrum and Molecular Landscape of Myeloid Disorders Harboring SF3B1 Mutations
Elise R. Venable et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2021)
Myelodysplastic syndromes: Biological and therapeutic consequences of the evolving molecular aberrations landscape
Sebastian Schwind et al.
NEOPLASIA (2021)
Mutational patterns and their correlation to CHIP-related mutations and age in hematological malignancies
Anna Stengel et al.
BLOOD ADVANCES (2021)
Validation of the international working group proposal for SF3B1 mutant myelodysplastic syndromes
Rami Komrokji et al.
BLOOD (2021)
SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS
Luca Malcovati et al.
BLOOD (2020)
The combination of WGS and RNA-Seq is superior to conventional diagnostic tests in multiple myeloma: Ready for prime time?
Alexander Hoellein et al.
CANCER GENETICS (2020)
Marrow Ring Sideroblasts Are Highly Predictive for TP53 Mutation in MDS with Excess Blasts
David M. Swoboda et al.
BLOOD (2019)
Molecular analysis of myelodysplastic syndrome with isolated deletion of the long arm of chromosome 5 reveals a specific spectrum of molecular mutations with prognostic impact: a study on 123 patients and 27 genes
Manja Meggendorfer et al.
HAEMATOLOGICA (2017)
Molecular analysis of myelodysplastic syndrome with isolated deletion of the long arm of chromosome 5 reveals a specific spectrum of molecular mutations with prognostic impact: a study on 123 patients and 27 genes
Manja Meggendorfer et al.
HAEMATOLOGICA (2017)
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
Daniel A. Arber et al.
BLOOD (2016)
SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts
Luca Malcovati et al.
BLOOD (2015)
Karyotype evolution and acquisition of FLT3 or RAS pathway alterations drive progression of myelodysplastic syndrome to acute myeloid leukemia
Manja Meggendorfer et al.
HAEMATOLOGICA (2015)
Karyotype evolution and acquisition of FLT3 or RAS pathway alterations drive progression of myelodysplastic syndrome to acute myeloid leukemia
Manja Meggendorfer et al.
HAEMATOLOGICA (2015)
Landscape of genetic lesions in 944 patients with myelodysplastic syndromes
T. Haferlach et al.
LEUKEMIA (2014)
Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence
Giulio Genovese et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes
Siddhartha Jaiswal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
The genetic basis of myelodysplasia and its clinical relevance
Mario Cazzola et al.
BLOOD (2013)
Clinical and biological implications of driver mutations in myelodysplastic syndromes
Elli Papaemmanuil et al.
BLOOD (2013)
Revised International Prognostic Scoring System for Myelodysplastic Syndromes
Peter L. Greenberg et al.
BLOOD (2012)
Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms
Luca Malcovati et al.
BLOOD (2011)
Frequent pathway mutations of splicing machinery in myelodysplasia
Kenichi Yoshida et al.
NATURE (2011)
Somatic SF3B1 Mutation in Myelodysplasia with Ring Sideroblasts
E. Papaemmanuil et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Determination of relapse risk based on assessment of minimal residual disease during complete remission by multiparameter flow cytometry in unselected patients with acute myeloid leukemia
W Kern et al.
BLOOD (2004)
Morphologic dysplasia in acute myeloid leukemia: Importance of granulocytic dysplasia - Reply
T Haferlach et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)